Lamb Weston Holdings, Inc. (NYSE: LW) Earnings Preview: A Look into the Frozen Foods Giant's Financial Health
Financial Modeling Prep· 2025-12-18 13:00
Lamb Weston Holdings, Inc. (NYSE:LW) is set to release its quarterly earnings with an expected EPS of $0.67 and projected revenue of $1.59 billion.The company faces a slight revenue decline but anticipates an EPS increase, showcasing its profitability resilience.Lamb Weston's financial metrics, including a P/E ratio of 28.20 and a debt-to-equity ratio of 2.23, highlight investor confidence and effective debt management.Lamb Weston Holdings, Inc. (NYSE:LW), a prominent figure in the frozen foods industry, co ...
Homerun Resources Inc. 100% Owned Subsidiary Homerun Energy SRL Recognized as Key Innovator by European Commission's Innovation Radar
TMX Newsfile· 2025-12-18 13:00
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Homerun Resources Inc. (TSXV: HMR) (OTCQB: HMRFF) ("Homerun" or the "Company") is pleased to announce that Homerun Energy SRL, a 100% owned subsidiary of Homerun Resources has been officially recognised as a Key Innovator by the European Commission's Innovation Radar for its contribution to a high-impact innovation developed within the E.T.COMPACT project, funded under the Horizon Europe programme.The innovation, titled "NIR-Optimized Flex ...
Werewolf Therapeutics Announces Pipeline and Business Updates
Globenewswire· 2025-12-18 13:00
WTX-124 initial Phase 1b expansion arm data showed 30% overall response rate as a monotherapy in a defined subset of post-ICI advanced or metastatic cutaneous melanoma patients, with potential best-in-class tolerability profileWTX-330 Phase 1b/2 trial initial data demonstrated additional evidence of antitumor activity and highly favorable tolerability profile, building upon monotherapy activity demonstrated in first-in-human Phase 1 clinical trialAdditional Phase 1/1b data update for WTX-124 and completion ...
GlobalTech Corporation Closes Acquisition of Majority Stake of Moda in Pelle
Globenewswire· 2025-12-18 13:00
RENO, Nev., Dec. 18, 2025 (GLOBE NEWSWIRE) -- GlobalTech Corporation (OTCID:GTLK)(“GTC” or “GlobalTech”), a U.S. based technology holding company focused on artificial intelligence (AI), big data, and emerging technologies, today announced the closing of the previously announced definitive purchase agreement to acquire a fifty one percent (51%) controlling interest in 123 Investments Limited d/b/a Moda in Pelle (“MIP”), a premium footwear brand established in 1975, with a strong presence in the UK market. T ...
Axalta Publishes 2023-2024 Sustainability Report
Globenewswire· 2025-12-18 13:00
PHILADELPHIA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems, Ltd. (Axalta) (NYSE: AXTA), a leading global coatings company, today announced the release of its 2023-2024 Sustainability Report. The report reflects the progress Axalta has made to advance the sustainability of the company’s operations and products, as well as its continued commitment to integrate sustainability into Axalta’s business strategy. “At Axalta, sustainability is aligned with our strategy to deliver superior products, servi ...
Revolution Medicines Announces First Patient Randomized in the RASolute 304 Clinical Trial of Daraxonrasib in Resectable Pancreatic Ductal Adenocarcinoma Following Adjuvant Chemotherapy
Globenewswire· 2025-12-18 13:00
REDWOOD CITY, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the first patient has been randomized in the RASolute 304 trial. RASolute 304 is a global, open-label, Phase 3 clinical trial evaluating the safety and efficacy of daraxonrasib, a RAS(ON) multi-selective inhibitor, in patients with resectable pancreatic ductal adenocarcinoma (PDAC) who have received surgery ...
Spartan Metals Provides Encouraging Drill Assay Results for Tungstonia Tailings at its Eagle Project, Nevada
Thenewswire· 2025-12-18 13:00
Core Insights - Spartan Metals Corp. announced positive assay results from the drilling program at the Tungstonia Tailings deposit, part of the Eagle Tungsten-Silver-Rubidium Project in eastern Nevada, indicating potential contributions to the US tungsten and rubidium supply chain [1][4][21] Summary by Sections Drilling Program - The drilling program consisted of 34 holes, approximately 6.4 centimeters in diameter, spaced about 12 meters apart, totaling around 67 meters and comprising 133 samples with an average depth of nearly 2 meters [1][3] Assay Results - The assay results showed tungsten grades averaging 0.13% WO3, silver grades of 10.6 g/t, and rubidium grades of 626 ppm, with consistent grades across all holes [5][8] - Notable highlights include specific intervals with tungsten grades reaching up to 0.42% WO3 and silver grades of 123 g/t [3][18] Economic Potential - The weighted average tungsten results are near the cutoff for currently operating mines, with the potential addition of silver and rubidium credits making the results encouraging [8] - The tailings have already been mined and processed, suggesting that the economic cutoff could be closer to the average of 0.13% WO3 obtained from the samples [8] Next Steps - The company plans to continue with Phase 1 of the work program, focusing on metallurgical analysis, tonnage calculations, 3D modeling, resource estimation, and economic evaluation to determine economic viability [9][10] - Two holes were drilled for geological and metallurgical testing to identify minerals hosting tungsten and rubidium and assess recoverability [10][11] Project Overview - The Eagle Project is one of the largest and highest-grade tungsten and rubidium districts in the US, covering approximately 36.5 km² and consisting of past-producing high-grade tungsten mines [21][22] - The project includes three deposit types: Porphyry, Skarn, and Carbonate Replacement, containing significant grades of tungsten, silver, and rubidium [23]
Carrier Connect Data Solutions Announces Customer Expansion at PureColo Subsidiary
Thenewswire· 2025-12-18 13:00
Core Insights - Carrier Connect Data Solutions Inc. has announced a significant expansion commitment from a leading co-location customer, which will add 90 Kilowatts starting February 2026, with final deployments expected by May 2026 [1][2] - The expansion represents a 58% increase in current billables, translating to an additional CAD $28,000 per month in revenue for the company [2] - The CEO of Carrier Connect expressed satisfaction with the rapid revenue growth following the acquisition of PureColo, highlighting the focus on profitable growth through customer expansion and new client acquisition [3] Company Overview - Carrier Connect Data Solutions Inc. aims to roll up Tier II/III data centers globally, specializing in co-location and data center solutions for AI companies, service providers, enterprises, and small businesses [4] - The company operates as a carrier-neutral organization, with its systems fully independent and owned within its leased space [4] - Current principal markets include Vancouver and Ottawa in Canada, and Perth in Australia, serving clients who utilize its facilities as primary or ancillary data centers [4]
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
Globenewswire· 2025-12-18 13:00
BERKELEY HEIGHTS, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced interim results for the Company’s ongoing real-world evidence study being conducted in conjunction with U.S. Renal Care’s (USRC) use of DefenCath in adult hemodialysis patients with central venous catheters. CorMedix and USRC commenced the real-world evidence stu ...
Restart Life Closes Over-Subscribed Second Tranche Financing
TMX Newsfile· 2025-12-18 13:00
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") announces that further to its news release dated November 12, 2025 and December 5, 2025, the Company has closed the over-subscribed second tranche of its non-brokered private placement for total gross proceeds of CDN$630,000 (the "Placement"). As announced on November 12, 2025, the company intended to raise a total of up to CDN$1,000,000 ...